PJ Online | PJ Letters: Type 2 diabetes
The Pharmaceutical Journal
Type 2 diabetes
From Mr J. Benouaich, MRPharmS
It is all very well to worry about the expense incurred by more people claiming medical exemptions for payment of prescription charges on the basis of their "newly diagnosed" diabetes. However the MeReC Bulletin (July 2002) says: "... it is likely that hundreds of thousands of people have undiagnosed type II diabetes." If these hundreds of thousands of people remain undiagnosed, the cost of their treatment in the future when the complications of diabetes become irreversible, eg, stroke, renal failure, will be much higher than the cost of exempting them now when the damage is still reversible after early diagnosis.
To exempt or not to exempt certain people with diabetes from prescription charges is a question that has to be tackled, but "tracking" these hundreds of thousands of people with undiagnosed type II diabetes should be a priority. Big savings to the National Health Service will be made if the disease is detected early.
Send your letter to The Editor
Citation: The Pharmaceutical Journal URI: 20007543
Recommended from Pharmaceutical Press
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00Buy now
Pharmacy Registration Assessment Questions 3 is the third volume in a series that follows on from the previous, highly popular Pharmacy Registration Assessment Questions 2. It features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own.£35.00Buy now